Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis

View through CrossRef
Resistance to therapy is a frequently observed phenomenon in the treatment of cancer, and as with other cancer therapeutics, therapies based on oncolytic viruses also face the challenges of resistance, such as humoral and cellular antiviral responses, and tumor-associated interferon-mediated resistance. In order to identify additional mechanisms of resistance that may contribute to therapeutic failure, we developed a systematic search strategy for studies published in PubMed. We analyzed 6143 articles on oncolytic virotherapy and found that approximately 8% of these articles use resistance terms in the abstract and/or title. Of these 439 articles, 87 were original research. Most of the findings reported pertain to resistance mediated by tumor-cell-dependent interferon signaling. Yet, mechanisms such as epigenetic modifications, hypoxia-mediated inhibition, APOBEC-mediated resistance, virus entry barriers, and spatiotemporal restriction to viral spread, although not frequently assessed, were demonstrated to play a major role in resistance. Similarly, our results suggest that the stromal compartment consisting of, but not limited to, myeloid cells, fibroblasts, and epithelial cells requires more study in relation to therapy resistance using oncolytic viruses. Thus, our findings emphasize the need to assess the stromal compartment and to identify novel mechanisms that play an important role in conferring resistance to oncolytic virotherapy.
Title: Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis
Description:
Resistance to therapy is a frequently observed phenomenon in the treatment of cancer, and as with other cancer therapeutics, therapies based on oncolytic viruses also face the challenges of resistance, such as humoral and cellular antiviral responses, and tumor-associated interferon-mediated resistance.
In order to identify additional mechanisms of resistance that may contribute to therapeutic failure, we developed a systematic search strategy for studies published in PubMed.
We analyzed 6143 articles on oncolytic virotherapy and found that approximately 8% of these articles use resistance terms in the abstract and/or title.
Of these 439 articles, 87 were original research.
Most of the findings reported pertain to resistance mediated by tumor-cell-dependent interferon signaling.
Yet, mechanisms such as epigenetic modifications, hypoxia-mediated inhibition, APOBEC-mediated resistance, virus entry barriers, and spatiotemporal restriction to viral spread, although not frequently assessed, were demonstrated to play a major role in resistance.
Similarly, our results suggest that the stromal compartment consisting of, but not limited to, myeloid cells, fibroblasts, and epithelial cells requires more study in relation to therapy resistance using oncolytic viruses.
Thus, our findings emphasize the need to assess the stromal compartment and to identify novel mechanisms that play an important role in conferring resistance to oncolytic virotherapy.

Related Results

CHALLENGES AND FUTURE PROSPECTS OF ONCOLYTIC VIROTHERAPY: A SYSTEMATIC REVIEW
CHALLENGES AND FUTURE PROSPECTS OF ONCOLYTIC VIROTHERAPY: A SYSTEMATIC REVIEW
Background: Oncolytic virotherapy has emerged as a novel and promising approach in cancer treatment, leveraging viruses that selectively infect and destroy malignant cells while sp...
Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Recent Progress and Emerging Trends
Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Recent Progress and Emerging Trends
Oncolytic virotherapy has emerged as a promising and innovative approach to cancer treatment, leveraging viruses that selectively replicate in tumor cells and cause their destructi...
Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy
Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy
Oncolytic virotherapy is a promising immunotherapy approach for cancer treatment, utilizing viruses to preferentially infect and eliminate cancer cells while stimulating immune res...
Dynamic analysis and optimal control of cancer oncolytic virotherapy model with chemotherapy and immune response
Dynamic analysis and optimal control of cancer oncolytic virotherapy model with chemotherapy and immune response
Abstract Oncolytic virotherapy is another therapeutic treatment for cancer and has been greatly interested recently by many researchers. In this study, a mathematical model...
Tumor Restrictions to Oncolytic Virus
Tumor Restrictions to Oncolytic Virus
Oncolytic virotherapy has advanced since the days of its conception but therapeutic efficacy in the clinics does not seem to reach the same level as in animal models. One reason is...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Analysis and Control of Oncolytic Virotherapy Dynamic Models
Analysis and Control of Oncolytic Virotherapy Dynamic Models
Oncolytic virotherapy is a cancer treatment that uses viruses to selectively infect and destroy cancer cells while leaving healthy cells unharmed. These viruses, known as oncolytic...
Is Oncolytic Virotherapy a permanent cure for malignant gliomas?
Is Oncolytic Virotherapy a permanent cure for malignant gliomas?
Of all malignant glioma forms, glioblastoma is the most frequently present form. The treatment of this highly aggressive tumor form by applying conventional therapies is of low suc...

Back to Top